184742191	184742191	CD	B-NP	O
|	|	NN	I-NP	O
HMH	HMH	NN	I-NP	O
|	|	NN	I-NP	O
11101800	11101800	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3536638	3536638	CD	B-NP	O
|	|	CC	I-NP	O
11/20/2005	11/20/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CONGESTIVE	CONGESTIVE	NNP	I-NP	I-protein
HEART	HEART	NNP	I-NP	I-protein
FAILURE	FAILURE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/20/2005	11/20/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/15/2005	10/15/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
WUITSCHICK	WUITSCHICK	NNP	B-NP	O
,	,	,	O	O
LEROY	LEROY	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Heart	Heart	NNP	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

LISTS	LISTS	NNS	B-NP	O
OF	OF	IN	B-PP	O
PROBLEMS	PROBLEMS	NNP	B-NP	O
AND	AND	CC	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
insulin-dependent	insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
,	,	,	O	O
hepatitis	hepatitis	NN	B-NP	O
B	B	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
osteoporosis	osteoporosis	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
L3	L3	NN	I-NP	O
compression	compression	NN	I-NP	O
fracture	fracture	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
left	leave	VBD	B-VP	O
hip	hip	NN	B-NP	O
fracture	fracture	NN	I-NP	O
with	with	IN	B-PP	O
replacement	replacement	NN	B-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
infection	infection	NN	B-NP	O
necessitating	necessitate	VBG	B-VP	O
removal	removal	NN	B-NP	O
,	,	,	O	O
debridement	debridement	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
deconditioning	deconditioning	NN	B-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Halnon	Halnon	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
67-year-old	67-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
comorbidities	comorbidity	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
transplant	transplant	NN	I-NP	O
in	in	IN	B-PP	O
1993	1993	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
hip	hip	NN	B-NP	O
replacement	replacement	NN	I-NP	O
in	in	IN	B-PP	O
September	September	NNP	B-NP	O
2005	2005	CD	I-NP	O
,	,	,	O	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
wound	wound	NN	B-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
need	need	VBP	B-VP	O
for	for	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
from	from	IN	B-PP	O
Port	Port	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
to	to	TO	B-PP	O
Ephma	Ephma	NNP	B-NP	O
Mersources	Mersources	NNP	I-NP	O
Ni	Ni	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
progressive	progressive	JJ	B-NP	O
worsening	worsen	VBG	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Ckmond	Ckmond	NNP	B-NP	O
Kinga	Kinga	NNP	I-NP	O
Quinaualv	Quinaualv	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
request	request	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Here	Here	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
was	be	VBD	B-VP	O
borderline	borderline	JJ	B-ADJP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
it	it	PRP	B-NP	O
improved	improve	VBD	B-VP	O
with	with	IN	B-PP	O
discontinuation	discontinuation	NN	B-NP	O
of	of	IN	B-PP	O
standing	stand	VBG	B-VP	O
analgesic	analgesic	JJ	B-ADJP	O
and	and	CC	O	O
decreasing	decrease	VBG	B-VP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
clonazepam	clonazepam	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
processes	process	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
arm	arm	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
and	and	CC	O	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
on	on	IN	B-PP	O
screening	screening	NN	B-NP	O
urinalysis	urinalysis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
anemic	anemic	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
vancomycin	vancomycin	NN	B-NP	O
resistant	resistant	JJ	I-NP	O
Enterococcus	Enterococcus	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
repeated	repeat	VBN	B-NP	O
cultures	culture	NNS	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
MRSA	MRSA	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
inpatient	inpatient	NN	I-NP	O
issues	issue	NNS	I-NP	O
included	include	VBD	B-VP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hip	hip	NN	I-NP	O
by	by	IN	B-PP	O
orthopedics	orthopedic	NNS	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
allergies	allergy	NNS	B-NP	O
to	to	TO	B-PP	O
penicillin	penicillin	NN	B-NP	O
and	and	CC	I-NP	O
codeine	codeine	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
the	the	DT	B-NP	O
reactions	reaction	NNS	I-NP	O
are	be	VBP	B-VP	O
unknown	unknown	JJ	B-ADJP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Vitamin	Vitamin	NNP	B-NP	O
C	C	NNP	I-NP	O
,	,	,	O	O
Imuran	Imuran	NNP	B-NP	O
,	,	,	O	O
PhosLo	PhosLo	NNP	B-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
,	,	,	O	O
Deltasone	Deltasone	NN	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
Aranesp	Aranesp	NN	B-NP	O
,	,	,	O	O
Dilaudid	Dilaudid	VBD	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
lactulose	lactulose	NN	B-NP	O
,	,	,	O	O
Reglan	Reglan	NNP	B-NP	O
,	,	,	O	O
Sarna	Sarna	NNP	B-NP	O
topical	topical	JJ	B-ADJP	O
,	,	,	O	O
Senokot	Senokot	NNP	B-NP	O
,	,	,	O	O
Ambien	Ambien	NNP	B-NP	O
for	for	IN	B-PP	O
sleep	sleep	NN	B-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
powder	powder	NN	I-NP	O
,	,	,	O	O
cyclosporine	cyclosporine	NN	B-NP	O
,	,	,	O	O
Celexa	Celexa	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Lasix	Lasix	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
130/57	130/57	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
pulse	pulse	NN	I-NP	O
120	120	CD	I-NP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
saturated	saturate	VBN	B-VP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

Physical	Physical	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
bibasilar	bibasilar	JJ	B-NP	O
crackles	crackle	NNS	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
legs	leg	NNS	I-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
knees	knee	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
5	5	CD	I-NP	O
cm	cm	NN	I-NP	O
x	x	SYM	B-NP	O
5	5	CD	B-NP	O
cm	cm	NN	I-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
warm	warm	JJ	B-NP	O
erythema	erythema	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
hip	hip	NN	I-NP	O
wound	wound	NN	I-NP	O
with	with	IN	B-PP	O
packing	packing	NN	B-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
granulation	granulation	NN	I-NP	O
tissue	tissue	NN	I-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
CT	CT	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
head	head	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
processes	process	NNS	I-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
right	right	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
and	and	CC	I-NP	O
structure	structure	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	NN	B-NP	O
to	to	TO	B-PP	O
moderately	moderately	RB	B-NP	O
reduced	reduce	VBN	I-NP	O
systolic	systolic	JJ	I-NP	O
function	function	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
.	.	.	O	O

Moderately	Moderately	RB	B-NP	O
dilated	dilate	VBN	I-NP	O
left	left	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
,	,	,	O	O
moderately	moderately	RB	B-NP	O
dilated	dilate	VBN	I-NP	O
right	right	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
,	,	,	O	O
normal	normal	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-PP	O
moderate	moderate	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
structurally	structurally	RB	B-NP	O
normal	normal	JJ	I-NP	O
tricuspid	tricuspid	JJ	I-NP	O
valve	valve	NN	I-NP	O
.	.	.	O	O

Right	Right	RB	B-NP	O
upper	upper	JJ	I-NP	O
arm	arm	NN	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
venous	venous	JJ	B-NP	O
obstruction	obstruction	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Gockley	Gockley	NNP	I-NP	O
's	's	POS	B-NP	O
inpatient	inpatient	NN	I-NP	O
issues	issue	NNS	I-NP	O
included	include	VBD	B-VP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
arm	arm	NN	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	I-NP	O
evaluation	evaluation	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
hip	hip	NN	I-NP	O
by	by	IN	B-PP	O
orthopedics	orthopedic	NNS	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
her	her	PRP$	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
and	and	CC	O	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	B-PP	O
oral	oral	JJ	B-NP	O
torsemide	torsemide	NN	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
entered	enter	VBD	B-VP	O
discharge	discharge	NN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
twice	twice	RB	I-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
weight	weight	NN	I-NP	O
was	be	VBD	B-VP	O
133	133	CD	B-NP	O
kg	kg	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
weight	weight	NN	I-NP	O
122	122	CD	I-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
current	current	JJ	I-NP	O
torsemide	torsemide	NN	I-NP	O
and	and	CC	O	O
limit	limit	VB	B-VP	O
her	her	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
salt	salt	NN	I-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
restrict	restrict	VB	B-VP	O
herself	herself	PRP	B-NP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
five-day	five-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
used	use	VBN	B-VP	O
to	to	TO	B-VP	O
address	address	VB	I-VP	O
recurrent	recurrent	JJ	B-NP	O
UTI	UTI	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	B-NP	O
then	then	RB	I-NP	O
a	a	DT	B-NP	O
two-day	two-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Ancef	Ancef	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
cleared	clear	VBD	B-VP	O
with	with	IN	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
her	her	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	O	O
transitioned	transitione	VBN	B-VP	O
to	to	TO	B-PP	O
Bactrim	Bactrim	NN	B-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
antibiogram	antibiogram	NN	B-NP	O
sensitivities	sensitivity	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
long-term	long-term	JJ	I-NP	O
Foley	Foley	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
cultures	culture	NNS	I-NP	O
showed	show	VBD	B-VP	O
bacteria	bacteria	NNS	B-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
urine	urine	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
clinically	clinically	RB	B-ADJP	O
asymptomatic	asymptomatic	JJ	I-ADJP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
more	more	RBR	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
colonization	colonization	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
treatment	treatment	NN	I-NP	O
was	be	VBD	B-VP	O
instituted	institute	VBN	I-VP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
PICC	PICC	NN	I-NP	O
line	line	NN	I-NP	O
clotted	clot	VBD	B-VP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
a	a	DT	B-NP	O
new	new	JJ	I-NP	O
Foley	Foley	NNP	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
incontinent	incontinent	JJ	B-ADJP	O
of	of	IN	B-PP	O
urine	urine	NN	B-NP	O
and	and	CC	O	O
overall	overall	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
comfortable	comfortable	JJ	I-ADJP	O
with	with	IN	B-PP	O
catheter	catheter	NN	B-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
on	on	IN	B-PP	O
Bactrim	Bactrim	NNP	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
UTI	UTI	NN	I-NP	B-DNA
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
rose	rise	VBD	B-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
peak	peak	NN	I-NP	O
of	of	IN	B-PP	O
2.0	2.0	CD	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
this	this	DT	B-NP	O
raise	raise	NN	I-NP	O
was	be	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
diuresis	diuresis	NN	B-NP	O
or	or	CC	O	O
the	the	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
cessation	cessation	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
trended	trend	VBD	B-VP	O
downward	downward	RB	B-ADVP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
at	at	IN	B-PP	O
1.6	1.6	CD	B-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
iron	iron	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
darbepoetin	darbepoetin	NN	B-NP	O
,	,	,	O	O
folate	folate	NN	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
asymptomatic	asymptomatic	JJ	B-ADJP	O
from	from	IN	B-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
two	two	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
in	in	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
two	two	CD	B-NP	O
more	more	JJR	I-NP	O
units	unit	NNS	I-NP	O
on	on	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
responded	respond	VBD	B-VP	O
appropriately	appropriately	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
30	30	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hip	hip	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
orthopedics	orthopedic	NNS	B-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
felt	feel	VBD	B-VP	O
her	her	PRP$	B-NP	O
hip	hip	NN	I-NP	O
was	be	VBD	B-VP	O
healing	heal	VBG	I-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
wet-to-dry	wet-to-dry	JJ	B-NP	O
dressings	dressing	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
further	further	JJ	I-NP	O
orthopedic	orthopedic	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
is	be	VBZ	B-VP	O
planned	plan	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
can	can	MD	B-VP	O
bear	bear	VB	I-VP	O
her	her	PRP$	B-NP	O
full	full	JJ	I-NP	O
weight	weight	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
hip	hip	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
,	,	,	O	O
afebrile	afebrile	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
breathing	breathing	NN	B-NP	O
comfortably	comfortably	RB	B-ADVP	O
on	on	IN	B-PP	O
three	three	CD	B-NP	O
liters	liter	NNS	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
Naor	Naor	NNP	B-NP	O
Viewmor	Viewmor	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
work	work	VB	I-VP	O
aggressively	aggressively	RB	B-ADVP	O
towards	towards	IN	B-PP	O
reconditioning	recondition	VBG	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Vitamin	Vitamin	NN	B-NP	O
C	C	NN	I-NP	O
500	500	CD	B-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Imuran	Imuran	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
PhosLo	PhosLo	NNP	B-NP	O
667	667	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
clonazepam	clonazepam	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
cyclosporine	cyclosporine	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	B-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Dilaudid	Dilaudid	VBD	B-VP	O
2	2	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
hold	hold	VBP	B-VP	O
this	this	DT	B-NP	O
sedated	sedate	VBN	B-VP	O
for	for	IN	B-PP	O
respirations	respiration	NNS	B-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
10	10	CD	I-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
14	14	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
every	every	DT	B-NP	O
evening	evening	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	I-protein
46	46	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
lactulose	lactulose	RB	B-NP	O
30	30	CD	I-NP	O
mL	mL	NN	I-NP	O
four	four	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
prednisone	prednisone	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
morning	morning	NN	I-NP	O
,	,	,	O	O
Sarna	Sarna	NNP	B-NP	O
topical	topical	JJ	I-NP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
areas	area	NNS	I-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	B-ADJP	O
,	,	,	O	O
goal	goal	NN	B-NP	O
INR	INR	NN	I-NP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
,	,	,	O	O
zinc	zinc	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
220	220	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Ambien	Ambien	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
before	before	IN	B-PP	O
bed	bed	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
insomnia	insomnia	NN	B-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
two	two	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Fosamax	Fosamax	NN	B-NP	O
70	70	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
nitrate	nitrate	NN	I-NP	O
2	2	CD	B-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	I-NP	O
two	two	CD	I-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
apply	apply	RB	B-ADVP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
areas	area	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
Diskus	Diskus	NNP	I-NP	O
250/50	250/50	CD	I-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
twice	twice	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
esomeprazole	esomeprazole	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
DuoNeb	DuoNeb	NNP	B-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
mg	mg	NN	I-NP	O
inhaled	inhale	VBD	B-VP	O
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
Aranesp	Aranesp	NN	B-NP	O
50	50	CD	I-NP	O
mcg	mcg	NN	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
once	once	RB	I-ADVP	O
per	per	IN	B-PP	O
week	week	NN	B-NP	O
,	,	,	O	O
NovoLog	NovoLog	NNP	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
before	before	IN	B-PP	O
meals	meal	NNS	B-NP	O
,	,	,	O	O
Lexapro	Lexapro	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
Maalox	Maalox	NNP	B-NP	O
one	one	CD	I-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
tablets	tablet	NNS	I-NP	O
every	every	DT	B-NP	O
six	six	CD	I-NP	O
hours	hour	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
upset	upset	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Lipitor	Lipitor	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

OUTSTANDING	OUTSTANDING	VBG	B-VP	O
ISSUES	ISSUES	NNS	B-NP	O
:	:	:	O	O
Include	Include	VBP	B-VP	O
following	follow	VBG	B-PP	O
INR	INR	NN	B-NP	O
the	the	DT	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
to	to	TO	B-PP	O
3	3	CD	B-NP	O
,	,	,	O	O
following	follow	VBG	B-PP	O
weight	weight	NN	B-NP	O
and	and	CC	O	O
clinical	clinical	JJ	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
following	follow	VBG	B-PP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
loose	loose	JJ	B-NP	O
stools	stool	NNS	I-NP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
Clostridium	Clostridium	NN	I-NP	O
difficile	difficile	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-VP	O
clinical	clinical	JJ	B-NP	O
signs	sign	NNS	I-NP	O
for	for	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
urinary	urinary	JJ	B-NP	O
tract	tract	NN	I-NP	O
infection	infection	NN	I-NP	O
treating	treat	VBG	B-VP	O
with	with	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
as	as	IN	B-PP	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

PRIMARY	PRIMARY	NN	B-NP	O
CARE	CARE	NN	I-NP	O
PHYSICIAN	PHYSICIAN	NN	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Rodolfo	Rodolfo	NNP	I-NP	O
Love	Love	NNP	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-3766097	4-3766097	CD	B-NP	O
SSSten	SSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Hyman	Hyman	NNP	B-NP	O
Footman	Footman	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Delp	Delp	NNP	I-NP	O
Coscotaence	Coscotaence	NNP	I-NP	O
Las	Las	NNP	I-NP	O
Newsbrid	Newsbrid	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
SINOR	SINOR	NNP	B-NP	O
,	,	,	O	O
ROGER	ROGER	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BRASSEAUX	BRASSEAUX	NNP	B-NP	O
,	,	,	O	O
JOSEPH	JOSEPH	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5980185	5980185	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/4/05	10/4/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/4/05	10/4/05	CD	B-NP	O

